Highlights and Quick Summary
- Current Ratio for the quarter ending December 31, 2022 was 4.41 (a -22.27% decrease compared to previous quarter)
- Year-over-year quarterly Current Ratio decreased by -4.79%
- Annual Current Ratio for 2022 was 1.9 (a 0.0% decrease from previous year)
- Annual Current Ratio for 2022 was 1.9 (a -87.35% decrease from previous year)
- Annual Current Ratio for 2021 was 15.05 (a 0.0% decrease from previous year)
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Current Ratio of Benitec Biopharma Limited
Most recent Current Ratioof BNTC including historical data for past 10 years.Interactive Chart of Current Ratio of Benitec Biopharma Limited
Benitec Biopharma Limited Current Ratio for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 4.41 | 5.67 | 1.9 | 4.63 | 1.9 |
| 2021 | 5.11 | 10.23 | 15.05 | 5.08 | 15.05 |
| 2020 | 18.46 | 7.91 | 9.52 | 12.97 | 9.52 |
| 2019 | – | – | – | 20.3 | 7.1 |
| 2018 | – | – | – | – | 8.2 |
| 2017 | – | – | – | 11.79 | 19.7 |
| 2016 | – | 21.71 | 18.81 | 12.02 | 18.73 |
| 2015 | – | – | 27.81 | 15.31 | 15.26 |
| 2014 | – | – | 41.97 | 36.36 | 36.08 |
| 2013 | 1.54 | – | – | – | 1.55 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology